본문 바로가기

Switching to rosuvastatin plus ezetimibe in statin-treated stroke patients with low-density lipoprotein cholesterol levels above 70 mg/dL (SWITCH): a prospective observational study

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q2
저널
LIPIDS IN HEALTH AND DISEASE24(1) · #359 · 2025
피인용
Web of Science 0Scopus 0
FWCI (Scopus)
0
JCR IF
JCR 2024 4.2
ISSN
1476-511X

저자

  1. Yang, Wookjin제1저자Asan Med Ctr, Dept Neurol, Seoul, South Korea
  2. Lee, Yeong-BaeGachon Univ, Coll Med, Gil Med Ctr, Dept Neurol, Incheon, South Korea
  3. Kim, Eung-GyuInje Univ, Busan Paik Hosp, Coll Med, Dept Neurol, Busan, South Korea
  4. 조한진Pusan Natl Univ, Sch Med, Pusan Natl Univ Hosp, Dept Neurol, Busan, South Korea
  5. Yu, SungwookKorea Univ, Anam Hosp, Coll Med, Dept Neurol, Seoul, South Korea
  6. Kim, Joon-TaeChonnam Natl Univ, Chonnam Natl Univ Hosp, Med Sch, Dept Neurol, Gwangju, South Korea
  7. Shin, Jong WookChungnam Natl Univ, Chungnam Natl Univ Hosp, Coll Med, Dept Neurol, Daejeon, South Korea
  8. Lee, Soo JooEulji Univ, Daejeon Eulji Med Ctr, Sch Med, Dept Neurol, Daejeon, South Korea
  9. Kim, Beom JoonSeoul Natl Univ, Bundang Hosp, Coll Med, Dept Neurol, Seongnam, South Korea
  10. Hong, Ji ManAjou Univ, Med Ctr, Sch Med, Dept Neurol, Suwon, South Korea
  11. Koh, Seong-HoHanyang Univ, Guri Hosp, Coll Med, Dept Neurol, Guri, South Korea
  12. An, Sang JoonCatholic Kwandong Univ, Int St Marys Hosp, Coll Med, Dept Neurol, Incheon, South Korea
  13. Cho, A-HyunCatholic Univ Korea, Yeouido St Marys Hosp, Coll Med, Dept Neurol, Seoul, South Korea
  14. Jung, Jin-ManKorea Univ, Coll Med, Ansan Hosp, Dept Neurol, Ansan, South Korea
  15. Cho, Hyun-JiCatholic Univ Korea, Coll Med, Incheon St Marys Hosp, Dept Neurol, Incheon, South Korea
  16. Kim, ChulhoHallym Univ, Chuncheon Sacred Heart Hosp, Coll Med, Dept Neurol, Chunchon, South Korea
  17. Lee, Eung-JoonSeoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Neurol, 101 Daehak Ro, Seoul 03080, South Korea
  18. Kim, Jeong-MinSeoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Neurol, 101 Daehak Ro, Seoul 03080, South Korea
  19. Lee, Seung-Hoon교신저자Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Neurol, 101 Daehak Ro, Seoul 03080, South Korea

초록

Background Effective lipid management is critical for secondary stroke prevention, however, many patients fail to achieve target low-density lipoprotein cholesterol (LDL-C) levels with statin monotherapy. This study evaluated the real-world effectiveness and safety of switching from statin monotherapy to rosuvastatin plus ezetimibe combination therapy (REZ) in patients with stroke. Methods This multicenter, prospective, observational study enrolled patients with stroke and baseline LDL-C >= 70 mg/dL despite statin monotherapy from 16 Korean stroke centers. Participants were switched to REZ at doses of 5/10 mg, 10/10 mg, or 20/10 mg at the investigators'discretion. Lipid profiles were assessed at three and six months. The primary outcome was achieving LDL-C < 70 mg/dL at six months. Results In total, 1,431 participants enrolled between May 2021 and March 2023 were eligible (mean age 65.3 +/- 10.6 years; 66.8% male). Among 994 participants completing follow-up, the mean baseline LDL-C was 98.9 +/- 22.4 mg/dL. At six months, 708 (71.2%) achieved LDL-C < 70 mg/dL. Mean LDL-C decreased to 62.7 +/- 22.1 mg/dL at three months and to 62.0 +/- 22.0 mg/dL at six months. The effectiveness of REZ remained consistent across different REZ dosages and regardless of changes in statin intensity during the switch. REZ was particularly effective in patients with diabetes (odds ratio [95% confidence interval], 1.85 [1.32-2.59]; P < 0.001) and baseline LDL-C 70-99 mg/dL (2.71 [2.04-3.59]; P < 0.001). Fewer participants achieved stricter targets (LDL-C < 55 mg/dL or LDL-C < 70 mg/dL plus 50% reduction). Conclusions Switching to REZ effectively reduced LDL-C in patients with stroke receiving statin monotherapy with LDL-C >= 70 mg/dL, offering potential benefits for secondary cardiovascular prevention in real-world practice.

키워드

EzetimibeHydroxymethylglutaryl-CoA reductase inhibitorsLow-density lipoprotein cholesterolStrokeCARDIOVASCULAR EVENTSTHERAPYRISKMETAANALYSISEFFICACYSAFETYTARGET

식별자

Scopus EID
2-s2.0-105021509995
WoS UID
001615498700001